APOTEX FDA Approval ANDA 207905

ANDA 207905

APOTEX

FDA Drug Application

Application #207905

Application Sponsors

ANDA 207905APOTEX

Marketing Status

Prescription001

Application Products

001TABLET;ORAL50MG0NALTREXONE HYDROCHLORIDENALTREXONE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-07-21STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

CHARTWELL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207905
            [companyName] => CHARTWELL
            [docInserts] => ["",""]
            [products] => [{"drugName":"NALTREXONE HYDROCHLORIDE","activeIngredients":"NALTREXONE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/21\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-07-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.